哮喘
医学
重症监护医学
流行病学
哮喘管理
哮喘的病理生理学
疾病
疾病管理
儿科
内科学
帕金森病
作者
Celeste Porsbjerg,Erik Melén,Lauri Lehtimäki,Dominick Shaw
出处
期刊:The Lancet
[Elsevier]
日期:2023-01-20
卷期号:401 (10379): 858-873
被引量:184
标识
DOI:10.1016/s0140-6736(22)02125-0
摘要
Asthma is one of the most common chronic non-communicable diseases worldwide and is characterised by variable airflow obstruction, causing dyspnoea and wheezing. Highly effective therapies are available; asthma morbidity and mortality have vastly improved in the past 15 years, and most patients can attain good asthma control. However, undertreatment is still common, and improving patient and health-care provider understanding of when and how to adjust treatment is crucial. Asthma management consists of a cycle of assessment of asthma control and risk factors and adjustment of medications accordingly. With the introduction of biological therapies, management of severe asthma has entered the precision medicine era—a shift that is driving clinical ambitions towards disease remission. Patients with severe asthma often have co-existing conditions contributing to their symptoms, mandating a multidimensional management approach. In this Seminar, we provide a clinically focused overview of asthma; epidemiology, pathophysiology, diagnosis, and management in children and adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI